Transgenic and physiological mouse models give insights into different aspects of amyotrophic lateral sclerosis

Abstract

A wide range of genetic mouse models is available to help researchers dissect human disease mechanisms. Each type of model has its own distinctive characteristics arising from the nature of the introduced mutation, as well as from the specific changes to the gene of interest. Here, we review the current range of mouse models with mutations in genes causative for the human neurodegenerative disease amyotrophic lateral sclerosis. We focus on the two main types of available mutants: transgenic mice and those that express mutant genes at physiological levels from gene targeting or from chemical mutagenesis. We compare the phenotypes for genes in which the two classes of model exist, to illustrate what they can teach us about different aspects of the disease, noting that informative models may not necessarily mimic the full trajectory of the human condition. Transgenic models can greatly overexpress mutant or wild-type proteins, giving us insight into protein deposition mechanisms, whereas models expressing mutant genes at physiological levels may develop slowly progressing phenotypes but illustrate early-stage disease processes. Although no mouse models fully recapitulate the human condition, almost all help researchers to understand normal and abnormal biological processes, providing that the individual characteristics of each model type, and how these may affect the interpretation of the data generated from each model, are considered and appreciated.

Role of Alcohol Drinking in Alzheimer’s Disease, Parkinson’s Disease, and Amyotrophic Lateral Sclerosis

“…The animal models of ALS can be prepared by a variety of genetic mutations [134]. These ALS mice or rats show signs of age-dependent progressive muscle weakness.…”

Moving neuromuscular disorders research forward: from novel models to clinical studies

“…We also published a number of comprehensive reviews. Examples include articles on the various mouse models of ALS (De Giorgio et al, 2019), on the roles of dystroglycans (Nickolls and Bönnemann, 2018) and collagen VI (Gregorio et al, 2018) in the nervous and muscular systems, and on the most recent insights from core myopathy model systems (Fusto et al, 2019).…”

Mouse models of neurodegeneration: Know your question, know your mouse

“…As FUS is a dose-sensitive gene, transgenic FUS mice do not model FUS-ALS well, whereas knockin models expressing pathogenic FUS mutations at physiological levels are excellent models of ALS, giving access to early stage disease processes (55,58). OtherALS genes such as C9orf72, or TARDBP which encodes the TDP-43 protein are also exquisitely dose sensitive (56,(59)(60)(61)(62).…”